Skip to main content

Table 5 Bivariate associations between Mycobacterium tuberculosis test type and other patient characteristics. Includes people initiating daily-dose isoniazid treatment (N = 1072)

From: Predictors of latent tuberculosis infection treatment completion in the US private sector: an analysis of administrative claims data

 

Mycobacterium tuberculosis Test Type

Tuberculin Skin Test

[% or Mean]

Interferon-Gamma Release Assay

[% or Mean]

Other/ Unknown Test

[% or Mean]

p-value

Sex

Female

42.1%

19.8%

38.1%

0.767

Male

40.0%

21.1%

38.8%

 

Age Group

0–14

75.2%

8.6%

16.1%

< 0.001

15–29

51.5%

11.0%

37.5%

 

30–44

36.1%

20.9%

43.0%

 

45–64

27.0%

31.3%

41.7%

 

Census Region

Northeast

46.6%

12.8%

40.6%

0.001

Midwest

36.8%

21.3%

41.9%

 

South

41.9%

21.6%

36.5%

 

West

37.9%

26.4%

35.7%

 

Patient Location

Large central metro county

41.1%

23.4%

35.5%

0.033

Large fringe metro county

44.1%

17.2%

38.7%

 

Any smaller county

34.3%

20.0%

45.7%

 

% of Households Under FPL in County

< 15%

41.9%

20.8%

37.3%

0.672

≥15%

40.1%

20.0%

39.9%

 

Insurance Type

HMO

38.8%

13.3%

47.9%

0.015

POS

41.1%

22.5%

36.4%

 

PPO

44.4%

19.0%

36.6%

 

Prescription Size

< 2 month supply

41.5%

20.0%

38.5%

0.428

≥2 month supply

37.0%

25.9%

37.0%

 

Year INH Regimen Started

2011 Q3–4

49.1%

23.2%

38.7%

0.001

2012 Q1–4

36.2%

21.8%

42.0%

 

2013 Q1–4

40.5%

24.9%

34.7%

 

2014 Q1

54.4%

15.2%

30.4%

 

State TB Rate

3.9

3.9

3.8

0.363

Percent Foreign Born in County

21.1

20.5

19.2

0.058

Count of Clinical Risk Factors

None

46.8%

14.5%

38.7%

< 0.001

1

36.8%

26.0%

37.2%

 

2 or more

17.9%

41.5%

40.6%

 

Diagnosis of Contact w/ TB

No diagnosis

39.8%

20.6%

39.6%

0.058

Had diagnosis

49.7%

19.5%

30.9%

 

History of TB/Late Effects

No diagnosis

42.0%

20.2%

37.9%

0.031

Had diagnosis

22.2%

36.7%

51.1%

 

HIV

No diagnosis

42.4%

19.0%

36.5%

< 0.001

Had diagnosis

9.5%

54.8%

35.7%

 

Diabetes

No diagnosis or medication

42.3%

19.8%

37.8%

0.010

Had diagnosis or medication

24.7%

28.8%

46.6%

 

Tobacco

No diagnosis or medication

42.1%

19.6%

38.3%

0.011

Had diagnosis or medication

26.5%

32.3%

41.2%

 

Immunosuppressive Medications

No medication

43.8%

16.7%

39.6%

< 0.001

Had medication

21.0%

49.2%

29.8%

 
  1. Abbreviations: INH isoniazid, FPL federal poverty level, TB tuberculosis, LTBI latent tuberculosis infection, HMO health maintenance organization, POS point of service, PPO preferred provider organization